| | | | | | | |
 | MODERNA, INC. | 1.01% | 1.00% | -45.81% | -14.76% | 543.69% | 54 740 |
 | LONZA GROUP AG | 1.01% | 1.35% | -26.42% | -2.54% | 77.40% | 42 618 |
| IQVIA HOLDINGS INC. | 0.77% | -1.48% | -27.91% | -14.89% | 51.29% | 38 497 |
| SEAGEN INC. | -0.21% | -2.24% | -9.87% | -9.13% | 104.82% | 25 649 |
| ICON PUBLIC LIMITED COMPANY | 0.68% | 3.35% | -29.74% | -5.84% | 57.07% | 17 688 |
 | CELLTRION, INC. | 1.38% | 3.16% | -25.76% | -44.16% | -11.03% | 16 131 |
| ALNYLAM PHARMACEUTICALS, INC. | -2.03% | 4.59% | -23.59% | -7.48% | 90.81% | 15 655 |
| BIO-TECHNE CORPORATION | -0.50% | 0.66% | -29.54% | -10.95% | 84.23% | 14 301 |
 | PHARMARON BEIJING CO., LTD. | -1.56% | 0.14% | -20.71% | -38.12% | 223.17% | 12 616 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | -0.60% | 0.02% | -38.63% | -29.33% | 80.04% | 11 748 |
| HANGZHOU TIGERMED CONSULTING CO., LTD | -1.83% | 0.21% | -31.63% | -50.62% | 93.46% | 10 986 |
| QIAGEN N.V. | 1.37% | -0.99% | -17.43% | -3.94% | 19.35% | 10 438 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | 0.68% | 1.71% | 3.77% | 80.67% | 135.55% | 10 159 |
| UNITED THERAPEUTICS CORPORATION | 11.58% | 13.51% | -2.75% | 11.35% | 144.38% | 9 519 |
| SYNEOS HEALTH, INC. | 0.79% | 2.16% | -30.40% | -17.96% | 71.14% | 7 331 |
| | | | | | | |
| | Durchschnitt | 0.84% | 1.81% | -23.76% | -10.51% | 117.69% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | 0.70% | 1.16% | -27.34% | -11.54% | 165.86% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
